[1]
C. Fournier, “Tebentafusp: A New Systemic Treatment for Unresectable or Metastatic Uveal Melanoma in HLA-A*02:01-positive patients”, Can Dermatol Today, vol. 4, no. 3, pp. 5–10, Sep. 2023.